Simultaneous determination of Aprepitant and two metabolites in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection
- 3 September 2004
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 35 (5) , 1213-1229
- https://doi.org/10.1016/j.jpba.2004.03.020
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Functional relevance of antiemetic controlEuropean Journal Of Cancer, 2003
- Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MSAnalytical Chemistry, 2003
- BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETSDrug Metabolism and Disposition, 2003
- Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomitingCancer, 2003
- Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonistsEuropean Journal Of Cancer, 2003
- Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomitingCancer, 2003
- Quantitative high‐throughput analysis of drugs in biological matrices by mass spectrometryMass Spectrometry Reviews, 2003
- Application of LC–NMR for the study of the volatile metabolite of MK-0869, a substance P receptor antagonistJournal of Pharmaceutical and Biomedical Analysis, 2002
- Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone AloneJournal of Clinical Oncology, 2001
- Matrix Effect in Quantitative LC/MS/MS Analyses of Biological Fluids: A Method for Determination of Finasteride in Human Plasma at Picogram Per Milliliter ConcentrationsAnalytical Chemistry, 1998